SCHEMBL6599976

SCHEMBL6599976

COc1nn(-c2ccc(NS(=O)(=O)c3ccc(OC)c(OC)c3)cc2)c(=O)o1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.56
HTT P42858 1/20 0.56
SMN1; SMN2 Q16637 1/20 0.56
CA12 O43570 1/20 0.54
CA9 Q16790 1/20 0.54
MEN1 O00255 4/20 0.52
KMT2A Q03164 4/20 0.52
ALOX15 P16050 1/20 0.52
MAPK1 P28482 1/20 0.52
TSHR P16473 2/20 0.52
ABHD16A O95870 1/20 0.51
ALDH1A1 P00352 4/20 0.51
MAPT P10636 3/20 0.50
HDAC4 P56524 1/20 0.49
HDAC1 Q13547 1/20 0.49
USP2 O75604 1/20 0.49
HSP90AA1 P07900 1/20 0.49
HSP90AB1 P08238 1/20 0.49
PKM P14618 1/20 0.47
NPSR1 Q6W5P4 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7044319 0.84 ABHD16A (0.53) LMNAKMT2AABHD16AALDH1A1MAPT
SCHEMBL6601531 0.84 ABHD16A (0.50) MEN1KMT2AABHD16AALDH1A1MAPT
SCHEMBL7045584 0.83 PGR (0.58) LMNAKMT2AMAPK1ABHD16AALDH1A1
SCHEMBL7040851 0.79 FFAR1 (0.53) LMNAABHD16AFAAHMGLL
SCHEMBL7040759 0.77 ABHD16A (0.58) ABHD16AFAAHMGLL
SCHEMBL7040692 0.76 MGLL (0.53) LMNAABHD16AALDH1A1MAPTHDAC4
SCHEMBL6073585 0.73 ALDH1A1 (0.62) LMNAHTTSMN1; SMN2CA12CA9
SCHEMBL7047556 0.72 MGLL (0.57) LMNAHTTMEN1KMT2AALOX15
SCHEMBL6601106 0.72 TP53 (0.62) HTTMEN1KMT2ATSHRALDH1A1
SCHEMBL94655 0.72 LMNA (0.77) LMNAHTTSMN1; SMN2CA12CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1263745-B1 SUBSTITUTED 3-PHENYL-5-ALKOXI-1,3,4-OXDIAZOL-2-ONE AND USE THEREOF FOR INHIBITING HORMONE-SENSITIVE LIPASE AVENTIS PHARMA GMBH (DE) 2004-05-19 EP disclosed